Bioventix PLC (LON:BVXP - Get Free Report) insider Bruce Hiscock acquired 300 shares of the stock in a transaction that occurred on Wednesday, October 30th. The stock was purchased at an average price of GBX 3,330 ($43.19) per share, with a total value of £9,990 ($12,955.52).
Bioventix Price Performance
BVXP traded up GBX 265 ($3.44) during mid-day trading on Thursday, hitting GBX 3,665 ($47.53). The stock had a trading volume of 7,511 shares, compared to its average volume of 5,336. Bioventix PLC has a 1-year low of GBX 2,977 ($38.61) and a 1-year high of GBX 5,100 ($66.14). The firm has a market capitalization of £191.31 million, a price-to-earnings ratio of 2,186.50 and a beta of 0.35. The stock's fifty day simple moving average is GBX 3,898.14 and its 200-day simple moving average is GBX 4,183.75.
Bioventix Increases Dividend
The firm also recently declared a dividend, which will be paid on Thursday, November 21st. Stockholders of record on Thursday, November 7th will be given a dividend of GBX 87 ($1.13) per share. The ex-dividend date of this dividend is Thursday, November 7th. This represents a dividend yield of 2.4%. This is a positive change from Bioventix's previous dividend of $68.00. Bioventix's dividend payout ratio (DPR) is currently 9,693.25%.
About Bioventix
(
Get Free Report)
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Recommended Stories
Before you consider Bioventix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioventix wasn't on the list.
While Bioventix currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
